Movano Inc
For the period ended Dec 31, 2024. Filed Apr 9, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
Compensation And Other Information Concerning Directors And Officers
Our compensation philosophy is to offer our executive officers compensation and benefits that are competitive and meet our goals of attracting, retaining and motivating highly skilled management, which is necessary to achieve our financial and strategic objectives and create long-term value for our stockholders. We believe the levels of compensation we provide should be competitive, reasonable and appropriate for our business needs and circumstances. The principal elements of our executive compensation program have to date included base salary and long-term equity compensation in the form of stock options. We believe successful long-term Company performance is more critical to enhancing stockholder value than short-term results. For this reason and to conserve cash and better align the interests of management and our stockholders, we emphasize long-term performance-based equity compensation over base annual salaries.
The following table sets forth information concerning the compensation earned by the individual that served as our Principal Executive Officer during 2024 and our two most highly compensated executive officers other than the individual who served as our Principal Executive Officer during 2024 (collectively, the “named executive officers”):
2024 Summary Compensation Table
| Name and Principal Position | Year | Salary ($) | Option Awards ($)(1) | Non-Equity Incentive Plan Compensation ($)(2) | All Other Compensation ($)(3) | TOTAL ($) |
|---|---|---|---|---|---|---|
| John Mastrototaro | 2024 | 361,042 | 268,876 | — | 16,351 | 646,269 |
| Chief Executive Officer | 2023 | 315,000 | 263,509 | — | 16,351 | 594,860 |
| Michael Leabman | 2024 | 347,500 | 268,876 | — | — | 616,376 |
| Chief Technology Officer | 2023 | 315,000 | 105,404 | — | — | 420,404 |
| J. Cogan | 2024 | 299,792 | 85,846 | — | — | 385,638 |
| Chief Financial Officer | 2023 | 270,000 | 148,346 | — | — | 418,346 |
| (1) | The amounts shown in this column indicate the grant date fair value of option awards granted in the subject year computed in accordance with FASB ASC Topic 718. For additional information regarding the assumptions made in calculating these amounts, see note 12 to our audited financial statements included with our annual report on Form 10-K for the year ended December 31, 2024 filed with the SEC. |
| (2) | The amounts under the Non-Equity Incentive Plan Compensation column reflect amounts earned under Movano’s annual performance bonus plan. |
| (3) | The amounts shown in this column represent reimbursement for certain health benefit plan premiums. |
Outstanding Equity Awards at 2024 Fiscal Year-End
The following table provides information regarding equity awards held by the named executive officers as of December 31, 2024.
| Option Awards · Stock Awards | |||||
|---|---|---|---|---|---|
| Name · Number of Securities Underlying Unexercised Options (#) Exercisable · Number of Securities Underlying Unexercised Options Unexercisable (#) · Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) · Option Exercise Price ($) · Option Expiration Date · Number of Shares or Units of Stock that have not Vested (#) · Market Value of Shares or Units of Stock that have not Vested ($) | |||||
| John Mastrototaro | 19,333 | - | 8.10 | 12/06/2030 | |
| Chief Executive Officer | 63,889 | 2,778 | (1) | 48.90 | 2/09/2031 |
| 6,937 | 2,063 | (2) | 75.00 | 11/15/2031 | |
| 9,844 | 12,656 | (3) | 19.35 | 3/20/2033 | |
| 75,848 | - | 7.05 | 5/15/2034 | ||
| Michael Leabman | 36,000 | - | 5.70 | 11/18/2029 | |
| Chief Technology Officer | 3,938 | 5,063 | (2) | 19.35 | 3/20/2033 |
| 75,848 | - | 7.05 | 5/15/2034 | ||
| J. Cogan | 5,333 | - | 30.00 | 12/06/2030 | |
| Chief Financial Officer | 3,431 | 993 | (4) | 75.00 | 11/15/2031 |
| 5,542 | 7,125 | (5) | 19.35 | 3/20/2033 | |
| 24,217 | - | 7.05 | 5/15/2034 | ||
| (1) | Represents the unvested portion of an option grant that vests in equal monthly installments of 1,389 shares each. |
| (2) | Represents the unvested portion of an option grant that vests in equal monthly installments of 188 shares each. |
| (3) | Represents the unvested portion of an option grant that vests in equal monthly installments of 469 shares each |
| (4) | Represents the unvested portion of an option grant that vests in equal monthly installments of 90 shares each. |
| (5) | Represents the unvested portion of an option grant that vests in equal monthly installments of 264 shares each. |
Employment Agreements and Change of Control Arrangements
Employment Agreements
The following is a summary of the employment arrangements with our named executive officers.
Michael Leabman. The Company entered into an “at-will” amended and restated offer letter with no fixed term with Mr. Leabman, the Company’s Chief Technology Officer and a Director, effective November 29, 2019, which was amended pursuant to a first amendment dated February 10, 2021 (as amended, the “Leabman Offer Letter”). Under the Leabman Offer Letter: (1) Mr. Leabman received an initial base salary of $250,000, which was adjusted to $315,000 in January 2022 and adjusted to $375,000 in June 2024, and is eligible to receive target performance bonuses equal to 80% of base salary (or any other amount approved by the Board), and (2) Mr. Leabman was awarded stock options to acquire 540,000 shares of common stock, one fourth of which options vested on the November 18, 2020, and the balance of which such options vested in 36 equal monthly installments thereafter. The Leabman Offer Letter provides that (1) if Mr. Leabman is terminated by the Company other than for Cause he is entitled to receive cash severance in an amount equal to 12 months of base salary plus a pro-rated amount of his target bonus based on the number of days he is employed during the year of termination and (2) if there occurs a Change in Control (as defined in the Omnibus Incentive Plan) and in the period prior to and in connection with or in anticipation of such Change in Control and ending on the one-year anniversary of the consummation of such Change in Control, Mr. Leabman is terminated by the Company other than for Cause, 100% of any such options that remain unvested will immediately vest. “Cause” includes, among other items, Mr. Leabman’s conviction of a felony involving fraud, misappropriation, embezzlement or dishonesty in conjunction with his duties to Company or repeated willful failure to perform his job duties as defined by the Board or uncured material breach of the Leabman Offer Letter or Mr. Leabman’s confidential information and inventions assignment agreement with the Company. Mr. Leabman is also entitled to participate in the Company’s regular health insurance and other employee benefit plans established by the Company for its employees from time to time.
J. Cogan. The Company has entered into an offer letter with J. Cogan, the Company’s Chief Financial Officer on similar terms to the agreement entered with Michael Leabman. Pursuant to his offer letter Mr. Cogan (1) received an initial base salary of $250,000, which was adjusted to $270,000 in January 2022 and adjusted to $325,000 in June 2024, (2) is entitled to a target performance bonus equal to 60% of base salary (or any other amount approved by the Board) and (3) was awarded stock options to acquire 455,000 shares of common stock, one fourth of which options vested on the one year anniversary of the grant date, and the balance of which such options vested in 36 equal monthly installments thereafter. Mr. Cogan’s Offer Letter provides for severance in connection with an involuntary termination and the acceleration of his stock options in connection with a Change of Control on identical terms as those described in the description of Mr. Leabman’s offer letter above.
John Mastrototaro. The Company entered into an offer letter with John Mastrototaro, the Company’s President, CEO and Director on similar terms to the agreement entered with Michael Leabman. Pursuant to his offer letter Mr. Mastrototaro (1) received an initial base salary of $300,000, which was adjusted to $315,000 in January 2022 and adjusted to $400,000 in June 2024, (2) is entitled to a target performance bonus equal to 80% of base salary (or any other amount approved by the Board) and (3) was awarded stock options to acquire 1,000,000 shares of common stock, one fourth of which options vested on the one year anniversary of the grant date, and the balance of which such options vest in 36 equal monthly installments thereafter. Mr. Mastrototaro’s Offer Letter provides for severance in connection with an involuntary termination and the acceleration of his stock options in connection with a Change of Control on identical terms as those described in the description of Mr. Leabman’s offer letter above.
Director Compensation
Each of our non-employee directors other than Ms. Fairbairn received stock option grants upon their appointment to the Board and Ms. Fairbairn received an option grant in September 2020. The options granted are subject to vesting with 1/48 th of the shares vesting for each month of continuous service. Pursuant to our non-employee director compensation policy our non-employee directors receive a $50,000 annual cash retainer plus the following additional annual cash fees: Chair of the Board, $25,000, Chair of the Audit Committee, $20,000 and Chair of the Compensation Committee, $10,000. Our non-employee director compensation policy provides that each director also receives options to purchase 20,000 shares of our common stock at the beginning of each year.
The following table sets forth information with respect to compensation earned by or awarded to each of our independent directors who served on the Board during the year ended December 31, 2024.
| Name | Fees Earned or Paid in Cash ($) | Option Awards ($)(1) | All Other Compensation | Total ($) |
|---|---|---|---|---|
| Rubén Caballero | 50,000 | 9,836 | — | 59,836 |
| Brian Cullinan | 80,000 | 9,836 | — | 89,836 |
| Emily Wang Fairbairn | 75,000 | 12,295 | — | 87,295 |
| Nan Kirsten Forte | 25,000 | 9,836 | — | 34,386 |
| Shaheen Wirk | — | — | — | — |
| (1) | The amounts shown in this column indicate the grant date fair value of option awards granted in the subject year computed in accordance with FASB ASC Topic 718. For additional information regarding the assumptions made in calculating these amounts, see note 9 to our audited financial statements included with our annual report on Form 10-K for the year ended December 31, 2024 filed with the SEC. The following table shows the number of shares subject to outstanding option awards and unvested stock awards held by each non-employee director as of December 31, 2024: |
| Name | Shares Subject to Outstanding Stock Option Awards (#) | Unvested Shares of Restricted Stock |
|---|---|---|
| Rubén Caballero | 40,000 | — |
| Brian Cullinan | 4,000 | — |
| Emily Wang Fairbairn | 4,667 | — |
| Nan Kirsten Forte | — | — |
| Shaheen Wirk | — | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.